SeaStar Medical, Inc., a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announced that it has completed its business combination with LMF Acquisition Opportunities. The deal closed today.
SeaStar Medical Holding stock and warrants are expected to begin trading on the Nasdaq on Oct. 31 under the new ticker symbols ICU and ICUCW.
Although redemptions wiped out all but about $3 million from LMFAO’s trust, other funding sources were sufficient to cover the minimum cash condition. In addition, HB Strategies this week signed an agreement sith the SPAC that would allow HB to purchase up to 700,000 shares in the open market and hold them for SeaStar’s benefit until the merger closed. In return HB stands to receive 50,000 shares free and clear. Read more.
